These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 33965062)
21. Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries. Atwell JE; Lutz CS; Sparrow EG; Feikin DR Vaccine; 2022 Jul; 40(32):4361-4370. PubMed ID: 35725783 [TBL] [Abstract][Full Text] [Related]
22. Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study. Krauer F; Guenther F; Treskova-Schwarzbach M; Schoenfeld V; Koltai M; Jit M; Hodgson D; Schneider U; Wichmann O; Harder T; Sandmann FG; Flasche S BMC Med; 2024 Oct; 22(1):478. PubMed ID: 39420374 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries. Getaneh AM; Li X; Mao Z; Johannesen CK; Barbieri E; van Summeren J; Wang X; Tong S; Baraldi E; Phijffer E; Rizzo C; van Wijhe M; Heikkinen T; Bont L; Willem L; Jit M; Beutels P; Bilcke J; Vaccine; 2023 Feb; 41(9):1623-1631. PubMed ID: 36737318 [TBL] [Abstract][Full Text] [Related]
24. Incidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015. Jepsen MT; Trebbien R; Emborg HD; Krause TG; Schønning K; Voldstedlund M; Nielsen J; Fischer TK Euro Surveill; 2018 Jan; 23(3):. PubMed ID: 29386093 [TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of strategies for preventing paediatric lower respiratory infections associated with respiratory syncytial virus in eight Chinese cities. Liu D; Leung K; Jit M; Wu JT Vaccine; 2021 Sep; 39(39):5490-5498. PubMed ID: 34454783 [TBL] [Abstract][Full Text] [Related]
26. Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals. Murray J; Saxena S; Sharland M Arch Dis Child; 2014 May; 99(5):469-73. PubMed ID: 24464977 [TBL] [Abstract][Full Text] [Related]
27. Adjustable Algorithmic Tool for Assessing the Effectiveness of Maternal Respiratory Syncytial Virus (RSV) Vaccination on Infant Mortality in Developing Countries. Cevigney R; Leary C; Gonik B Infect Dis Obstet Gynecol; 2021; 2021():5536633. PubMed ID: 34121834 [TBL] [Abstract][Full Text] [Related]
28. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal. Chu HY; Tielsch J; Katz J; Magaret AS; Khatry S; LeClerq SC; Shrestha L; Kuypers J; Steinhoff MC; Englund JA J Clin Virol; 2017 Oct; 95():90-95. PubMed ID: 28903080 [TBL] [Abstract][Full Text] [Related]
29. Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand. Prasad N; Read JM; Jewell C; Waite B; Trenholme AA; Huang QS; Grant CC; Newbern EC; Hogan AB Vaccine; 2021 Jul; 39(31):4383-4390. PubMed ID: 34147296 [TBL] [Abstract][Full Text] [Related]
30. New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants. Srikantiah P; Klugman KP BMC Med; 2023 May; 21(1):177. PubMed ID: 37183242 [TBL] [Abstract][Full Text] [Related]
31. The role of birth month in the burden of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in Croatia. Li Y; Batinović E; Milić P; Markić J PLoS One; 2022; 17(9):e0273962. PubMed ID: 36054117 [TBL] [Abstract][Full Text] [Related]
32. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Nair H; Nokes DJ; Gessner BD; Dherani M; Madhi SA; Singleton RJ; O'Brien KL; Roca A; Wright PF; Bruce N; Chandran A; Theodoratou E; Sutanto A; Sedyaningsih ER; Ngama M; Munywoki PK; Kartasasmita C; Simões EA; Rudan I; Weber MW; Campbell H Lancet; 2010 May; 375(9725):1545-55. PubMed ID: 20399493 [TBL] [Abstract][Full Text] [Related]
33. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024. Moline HL; Tannis A; Toepfer AP; Williams JV; Boom JA; Englund JA; Halasa NB; Staat MA; Weinberg GA; Selvarangan R; Michaels MG; Sahni LC; Klein EJ; Stewart LS; Schlaudecker EP; Szilagyi PG; Schuster JE; Goldstein L; Musa S; Piedra PA; Zerr DM; Betters KA; Rohlfs C; Albertin C; Banerjee D; McKeever ER; Kalman C; Clopper BR; ; McMorrow ML; Dawood FS MMWR Morb Mortal Wkly Rep; 2024 Mar; 73(9):209-214. PubMed ID: 38457312 [TBL] [Abstract][Full Text] [Related]
34. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Wang X; Li Y; O'Brien KL; Madhi SA; Widdowson MA; Byass P; Omer SB; Abbas Q; Ali A; Amu A; Azziz-Baumgartner E; Bassat Q; Abdullah Brooks W; Chaves SS; Chung A; Cohen C; Echavarria M; Fasce RA; Gentile A; Gordon A; Groome M; Heikkinen T; Hirve S; Jara JH; Katz MA; Khuri-Bulos N; Krishnan A; de Leon O; Lucero MG; McCracken JP; Mira-Iglesias A; Moïsi JC; Munywoki PK; Ourohiré M; Polack FP; Rahi M; Rasmussen ZA; Rath BA; Saha SK; Simões EA; Sotomayor V; Thamthitiwat S; Treurnicht FK; Wamukoya M; Yoshida LM; Zar HJ; Campbell H; Nair H; Lancet Glob Health; 2020 Apr; 8(4):e497-e510. PubMed ID: 32087815 [TBL] [Abstract][Full Text] [Related]
35. Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets. Reeves RM; van Wijhe M; Tong S; Lehtonen T; Stona L; Teirlinck AC; Fernandez LV; Li Y; Giaquinto C; Fischer TK; Demont C; Heikkinen T; Speltra I; van Boven M; Bøås H; Campbell H; J Infect Dis; 2020 Oct; 222(Suppl 7):S599-S605. PubMed ID: 32815542 [TBL] [Abstract][Full Text] [Related]
36. Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants. Suryadevara M J Pediatric Infect Dis Soc; 2024 Jul; 13(Supplement_2):S110-S114. PubMed ID: 38995085 [TBL] [Abstract][Full Text] [Related]
37. Variability in the Timing of Respiratory Syncytial Virus Epidemics in Guatemala, 2008-2018. Hamid S; Grajeda LM; de Leon O; Lopez MR; Maldonado H; Gomez AB; Lopman B; Clasen TF; McCracken JP Influenza Other Respir Viruses; 2024 Jul; 18(7):e13334. PubMed ID: 38980961 [TBL] [Abstract][Full Text] [Related]
38. The contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015. Hardelid P; Verfuerden M; McMenamin J; Smyth RL; Gilbert R Euro Surveill; 2019 Jan; 24(1):. PubMed ID: 30621817 [TBL] [Abstract][Full Text] [Related]
39. Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries. Carbonell-Estrany X; Rodgers-Gray BS; Paes B Expert Rev Anti Infect Ther; 2021 Apr; 19(4):419-441. PubMed ID: 32972198 [TBL] [Abstract][Full Text] [Related]
40. Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study. Brault A; Pontais I; Enouf V; Debeuret C; Bloch E; Paireau J; Rameix-Welti MA; White M; Baudemont G; Lina B; Parent du Châtelet I; Casalegno JS; Vaux S; Cauchemez S Lancet Child Adolesc Health; 2024 Oct; 8(10):721-729. PubMed ID: 39208833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]